Pluristem Therapeutics Inc Shares Close the Day 10.3% Higher - Daily Wrap
The company saw its shares close the day 10.3% higher than yesterday, with trading volume higher than its 30 day average.
Jan 16, 2022 by Kwhen Finance Editors
Pluristem Therapeutics Inc (PSTI) shares closed today 10.3% higher than it did at the end of yesterday. The stock is currently up 32.2% year-to-date, down 76.0% over the past 12 months, and down 87.6% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%.
Trading Activity
- Shares traded as high as $2.04 and as low as $1.65 this week.
- Shares closed 77.6% below its 52-week high and 41.9% above its 52-week low.
- Trading volume this week was 96.1% lower than the 10-day average and 88.5% lower than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.5.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Pluristem Therapeutics Inc | 10.3 | 32.2 | -76.0 | -79.7 | 28.7 |
| Dow Jones Industrial Average | -0.6 | -1.2 | 18.5 | -3.1 | 22.0 |
| S&P 500 Index | 0.0 | -2.2 | 25.3 | -3.9 | 26.9 |
| Health Care | -0.2 | -5.7 | 12.9 | -6.8 | 19.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -525.5%
- The company's stock price performance over the past 12 months lags the peer average by 130.9%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Pluristem Therapeutics Inc | PSTI | 0 | 32.2 | -76.0 | -79.7 | 28.7 |
| Peer Avg | N/A | 1.5 | -7.6 | -32.9 | -59.7 | 9.7 |
| United Therapeutics Corp | UTHR | 20.8 | -1.0 | 23.8 | -4.6 | 35.4 |
| Geron Corp. | GERN | -3.6 | -1.6 | -29.2 | -52.5 | 0.9 |
| Compugen Ltd | CGEN | -9.6 | -9.5 | -70.1 | -73.0 | 3.8 |
| Athersys Inc | ATHX | 0 | -2.9 | -56.4 | -72.6 | 2.5 |
| Brooklyn ImmunoTherapeutics Inc | BTX | 0 | -22.8 | -32.6 | -95.9 | 5.8 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: